United Kingdom (UK) We have just launched a quarterly e-newsletter where we give our take on some of the latest developments in the field of engineered antibodies. We also include updates on our technologies, products and services, and offer exclusive deals.
If you would like to subscribe, just submit your email using the form below. You can opt out at any time.